Software Patents,New
Software Patents,New

Software Patents,New

In Stock
SKU: DADAX1726619990
Brand: Independently Published
Condition: New
Regular price$45.82
Quantity
Add to wishlist
Add to compare

Sold by Ergodebooks, an authorized reseller.

Returns accepted within 30 days | support@ergodebooks.com

Verified
Shipping Information
  • Free Standard Shipping — United States only
  • Processing Time: 1–3 business days
  • Estimated Delivery: 3–5 business days after dispatch
  • Double-boxed, fully insured & discreetly packaged
  • Tracking number sent via email once dispatched
  • Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund

Returns accepted within 30 days of delivery.

Damaged or Defective Item

Free return shipping + replacement or full refund

Wrong Item Received

Free return shipping + replacement or full refund

Change of Mind

Return shipping at customer's expense · 25% restocking fee applies

All returns require a Return Authorization (RA) number before sending.

To initiate a return, contact us:

support@ergodebooks.com +1 (281) 738-1050
View Full Return & Refund Policy
Payment Option
Payment Methods

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

THIS CASEBOOK contains a selection of U. S. Court of Appeals decisions that analyze and discuss issues surrounding software patents and other computerimplemented method patents. * * * Section 101 provides that a patent may be obtained for 'any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof.' 35 U.S.C. 101. The Supreme Court has long recognized, however, that 101 implicitly excludes 'laws of nature, natural phenomena, and abstract ideas' from the realm of patenteligible subject matter, as monopolization of these 'basic tools of scientific and technological work' would stifle the very innovation that the patent system aims to promote. Alice Corp. v. CLS Bank Int'l, ___ U.S. ___, 134 S.Ct. 2347, 2354, 189 L.Ed.2d 296 (2014) (quoting Ass'n for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576, 133 S.Ct. 2107, 2116, 186 L.Ed.2d 124 (2013)); see also Mayo Collaborative Servs. v. Prometheus Labs., Inc., 566 U.S. 66, 132 S.Ct. 1289, 129497, 182 L.Ed.2d 321 (2012); Diamond v. Diehr, 450 U.S. 175, 185, 101 S.Ct. 1048, 67 L.Ed.2d 155 (1981). Finjan, Inc. v. Blue Coat Systems, Inc., 879 F. 3d 1299 (Fed. Cir. 2018). The Supreme Court has instructed us to use a twostep framework to 'distinguish[ ] patents that claim laws of nature, natural phenomena, and abstract ideas from those that claim patenteligible applications of those concepts.' Alice, 134 S.Ct. at 2355. At the first step, we determine whether the claims at issue are 'directed to' a patentineligible concept. Id. If they are, we then 'consider the elements of each claim both individually and 'as an ordered combination' to determine whether the additional elements 'transform the nature of the claim' into a patenteligible application.' Id. (quoting Mayo, 132 S.Ct. at 1298). This is the search for an 'inventive concept' something sufficient to ensure that the claim amounts to 'significantly more' than the abstract idea itself. Id. (quoting Mayo, 132 S.Ct. at 1294). Finjan, Inc. v. Blue Coat Systems, Inc., ibid.

⚠️ WARNING (California Proposition 65):

This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.

For more information, please visit www.P65Warnings.ca.gov.

Recently Viewed